Jean-Pierre Vilque Selected Research

Jean-Pierre Vilque Research Topics

5	Neoplasms (Cancer) 01/2021 - 05/2005
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 01/2018
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 05/2005
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 02/2016
2	Lymphoma (Lymphomas) 06/2018 - 01/2018
2	Infections 02/2018 - 11/2015
2	Leukemia 01/2017 - 11/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2015 - 01/2009
1	Cardiotoxicity 01/2021
1	Pathologic Complete Response 01/2021
1	Atrial Fibrillation 01/2021
1	Mucositis 06/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2018
1	Water Intoxication 06/2018
1	Colitis 06/2018
1	Pneumonia (Pneumonitis) 06/2018
1	Gastroenteritis 06/2018
1	Neutropenia 02/2018
1	Residual Neoplasm 01/2016
1	Heart Failure 11/2015
1	Acute Coronary Syndrome 11/2015
1	Stroke (Strokes) 11/2015
1	Transient Ischemic Attack 11/2015
1	Multiple Myeloma 02/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2013
1	Disease Progression 01/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2013
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2013
1	GATA2 Deficiency 01/2009
1	Philadelphia Chromosome 01/2002
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2002
1	Rare Diseases (Rare Disease) 01/2002

3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 05/2005
3	fludarabineIBA 01/2021 - 02/2016
3	Bendamustine Hydrochloride FDA Link 06/2018 - 01/2013
2	ibrutinibIBA 01/2021 - 01/2017
2	obinutuzumabIBA 01/2021 - 01/2021
2	Rituximab (Mabthera)FDA Link 02/2018 - 02/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009 - 05/2005
1	midostaurinIBA 01/2021
1	taxaneIBA 01/2021
1	pomalidomideIBA 01/2021
1	nilotinib FDA Link 01/2021
1	ponatinibIBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	Clofarabine (Clolar)FDA Link 01/2021
1	Immunomodulating AgentsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	AntimetabolitesIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 11/2019
1	Carmustine (FIVB)FDA Link 06/2018
1	Etoposide (VP 16)FDA LinkGeneric 06/2018
1	RadiopharmaceuticalsIBA 01/2018
1	TroponinIBA 11/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2015
1	Bortezomib (Velcade)FDA Link 02/2015
1	Gemtuzumab (Mylotarg)FDA Link 01/2015
1	Prednisone (Sone)FDA LinkGeneric 05/2005
1	InterferonsIBA 05/2005
1	Teniposide (VM 26)FDA Link 05/2005
1	Interferon-alpha (Interferon Alfa)IBA 01/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2002
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2002

6	Drug Therapy (Chemotherapy) 01/2016 - 05/2005
5	Therapeutics 01/2021 - 01/2002
3	Stem Cell Transplantation 06/2018 - 05/2005
1	Immunotherapy 01/2018
1	Hematopoietic Stem Cell Transplantation 11/2015
1	Length of Stay 11/2015
1	Transplantation 05/2005